Verheul HM - Search Results

1

Predictive biomarkers in renal cell cancer: insights in drug resistance mechanisms.

van der Mijn JC, Mier JW, Broxterman HJ, Verheul HM. van der Mijn JC, et al. Among authors: verheul hm. Drug Resist Updat. 2014 Oct-Dec;17(4-6):77-88. doi: 10.1016/j.drup.2014.10.003. Epub 2014 Oct 7. Drug Resist Updat. 2014. PMID: 25457974 Review.

2

Platelet: transporter of vascular endothelial growth factor.

Verheul HM, Hoekman K, Luykx-de Bakker S, Eekman CA, Folman CC, Broxterman HJ, Pinedo HM. Verheul HM, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2187-90. Clin Cancer Res. 1997. PMID: 9815613

3

Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas.

Verheul HM, Hoekman K, Lupu F, Broxterman HJ, van der Valk P, Kakkar AK, Pinedo HM. Verheul HM, et al. Clin Cancer Res. 2000 Jan;6(1):166-71. Clin Cancer Res. 2000. PMID: 10656446

4

Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets.

Verheul HM, Jorna AS, Hoekman K, Broxterman HJ, Gebbink MF, Pinedo HM. Verheul HM, et al. Blood. 2000 Dec 15;96(13):4216-21. Blood. 2000. PMID: 11110694 Free article.

5

Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.

van Hensbergen Y, Broxterman HJ, Hanemaaijer R, Jorna AS, van Lent NA, Verheul HM, Pinedo HM, Hoekman K. van Hensbergen Y, et al. Among authors: verheul hm. Clin Cancer Res. 2002 Dec;8(12):3747-54. Clin Cancer Res. 2002. PMID: 12473585

6

Proteomics of the TRAP-induced platelet releasate.

Piersma SR, Broxterman HJ, Kapci M, de Haas RR, Hoekman K, Verheul HM, Jiménez CR. Piersma SR, et al. Among authors: verheul hm. J Proteomics. 2009 Feb 15;72(1):91-109. doi: 10.1016/j.jprot.2008.10.009. Epub 2008 Nov 8. J Proteomics. 2009. PMID: 19049909

7

Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib.

Vroling L, van der Veldt AA, de Haas RR, Haanen JB, Schuurhuis GJ, Kuik DJ, van Cruijsen H, Verheul HM, van den Eertwegh AJ, Hoekman K, Boven E, van Hinsbergh VW, Broxterman HJ. Vroling L, et al. Among authors: verheul hm. Angiogenesis. 2009;12(1):69-79. doi: 10.1007/s10456-009-9133-9. Epub 2009 Feb 11. Angiogenesis. 2009. PMID: 19212818 Free article.

8

Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib.

Broxterman HJ, Gotink KJ, Verheul HM. Broxterman HJ, et al. Among authors: verheul hm. Drug Resist Updat. 2009 Aug-Oct;12(4-5):114-26. doi: 10.1016/j.drup.2009.07.001. Epub 2009 Aug 3. Drug Resist Updat. 2009. PMID: 19648052 Review.

9

The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma.

Verheul HM, van Erp K, Homs MY, Yoon GS, van der Groep P, Rogers C, Hansel DE, Netto GJ, Pili R. Verheul HM, et al. Urology. 2010 Mar;75(3):608-14. doi: 10.1016/j.urology.2009.05.075. Epub 2009 Aug 15. Urology. 2010. PMID: 19683801

10

CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients.

Vroling L, Lind JS, de Haas RR, Verheul HM, van Hinsbergh VW, Broxterman HJ, Smit EF. Vroling L, et al. Among authors: verheul hm. Br J Cancer. 2010 Jan 19;102(2):268-75. doi: 10.1038/sj.bjc.6605477. Epub 2009 Dec 15. Br J Cancer. 2010. PMID: 20010948 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters